According to Viridian Therapeutics's latest financial reports the company's current revenue (TTM ) is โน6.37 Billion. In 2024 the company made a revenue of โน25.9 Million a decrease over the revenue in the year 2023 that were of โน26.14 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.